Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis.
Vigna-Pérez, M
Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis. [electronic resource] - Clinical and experimental immunology Aug 2005 - 372-80 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0009-9104
10.1111/j.1365-2249.2005.02859.x doi
Adalimumab
Adult
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antigens, Bacterial--immunology
Antirheumatic Agents--therapeutic use
Apoptosis--drug effects
Arthritis, Rheumatoid--drug therapy
CD4-Positive T-Lymphocytes--immunology
Cells, Cultured
Female
Humans
Immune Tolerance--drug effects
Lymphocyte Count
Middle Aged
Mycobacterium tuberculosis--immunology
Pilot Projects
T-Lymphocyte Subsets--drug effects
Tuberculin Test
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis. [electronic resource] - Clinical and experimental immunology Aug 2005 - 372-80 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0009-9104
10.1111/j.1365-2249.2005.02859.x doi
Adalimumab
Adult
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antigens, Bacterial--immunology
Antirheumatic Agents--therapeutic use
Apoptosis--drug effects
Arthritis, Rheumatoid--drug therapy
CD4-Positive T-Lymphocytes--immunology
Cells, Cultured
Female
Humans
Immune Tolerance--drug effects
Lymphocyte Count
Middle Aged
Mycobacterium tuberculosis--immunology
Pilot Projects
T-Lymphocyte Subsets--drug effects
Tuberculin Test
Tumor Necrosis Factor-alpha--antagonists & inhibitors